MedPath

Skelaxin

SKELAXIN (Metaxalone) Tablets

Approved
Approval ID

cb47d76e-a7e3-4bac-8074-8d7e95c6a6eb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-123
Application NumberNDA013217
Product Classification
M
Marketing Category
C73594
G
Generic Name
Metaxalone
Product Specifications
Route of AdministrationORAL
Effective DateJune 12, 2007
FDA Product Classification

INGREDIENTS (1)

MetaxaloneActive
Quantity: 800 mg in 1 1
Code: 1NMA9J598Y
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Skelaxin - FDA Drug Approval Details